No Data
No Data
Biotech Bankruptcies Hit a Record Despite Sector's Recovery
Cell Reports Medicine Publication Demonstrates How Gelesis' Oral Therapeutic Hydrogel Promotes Weight Loss and Metabolic Health by Targeting the Gut-Liver Axis in Pre-Clinical Studies
Express News | Orgenesis Names Elliot Maltz Chief Financial Officer
Gelesis' Oral Treatment for Weight Management Showed Real-World Effectiveness in New Data Presented at the American Diabetes Association's Annual Conference
Gelesis (NYSE:GLS) Trading Up 0.4%
Express News | News On Gelesis Holdings Inc. (GLS) Now Under GLSH